Answers are grounded in this paper and cite their sources.
Glucagon was significantly under-prescribed in this high-risk population, highlighting gaps in applying clinical guidelines to practice as well as gaps in access to preventive care. These findings will inform provider education and interventions to improve glucagon-prescribing practices.
No takes yet. Share an insight, caveat, or question.
Arellano et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: